3740 Total Publications
Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Ourselin, S., & Fox, N. C.
2013; Journal Neurology; vol. 80; no. 7; pp. 648-54;
doi:10.1212/WNL.0b013e318281ccd3
White matter hyperintensities and cerebral amyloidosis: Necessary and sufficient for clinical expression of Alzheimer’s disease?
Provenzano, F. A., Muraskin, J., Tosto, G., Narkhede, A., Wasserman, B. T., Griffith, E. Y., … Brickman, A. M.
PMID: 23420027
;
PMCID:4124641
; 2013; Journal JAMA Neurology; vol. 70; no. 4; pp. 455-461;
doi:10.1001/jamaneurol.2013.1321
Unbiased Tensor-Based Morphometry: Improved Robustness and Sample Size Estimates for Alzheimer's Disease Clinical Trials.
Hua, X., Hibar, D. P., Ching, C. R. K., Boyle, C. P., Rajagopalan, P., Gutman, B. A., … Thompson, P. M.
PMID: 23153970
;
PMCID:3785376
; 2013; Journal Neuroimage; vol. 66; pp. 648-61;
doi:10.1016/j.neuroimage.2012.10.086
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration.
Rahul S Desikan, Wesley K Thompson, Dominic Holland, Christopher P Hess, James B Brewer, Henrik Zetterberg, Kaj Blennow, Ole A Andreassen, Linda K McEvoy, Bradley T Hyman, Anders M Dale, and for the Alzheimer’s Disease Neuroimaging Initiative.
2013; Journal Molecular Neurodegeneration; vol. 8; no. 39;
doi:10.1186/1750-1326-8-39
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease.
Lambert, J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., … Amouyel, P.
2013; Journal Nature Genetics; vol. 45; no. 12; pp. 1452-8;
doi:10.1038/ng.2802